Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Other Non-Current Assets (2023 - 2025)

Compass Therapeutics (CMPX) has disclosed Other Non-Current Assets for 3 consecutive years, with $568000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets changed 0.0% to $568000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $568000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $568000.0 for FY2025, 0.0% changed from the prior year.
  • Other Non-Current Assets hit $568000.0 in Q4 2025 for Compass Therapeutics, roughly flat from $568000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $568000.0 in Q3 2024 to a low of $320000.0 in Q1 2023.
  • Historically, Other Non-Current Assets has averaged $444000.0 across 3 years, with a median of $444000.0 in 2023.
  • Biggest YoY gain for Other Non-Current Assets was 77.5% in 2024; the steepest drop was 0.0% in 2024.
  • Year by year, Other Non-Current Assets stood at $320000.0 in 2023, then surged by 77.5% to $568000.0 in 2024, then changed by 0.0% to $568000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for CMPX at $568000.0 in Q4 2025, $568000.0 in Q3 2025, and $568000.0 in Q2 2025.